|4.14||-0.32 / -7.17%|
Data as of 4:00pm ET
|4.11||-0.03 / -0.72%|
The 2 analysts offering 12-month price forecasts for Northwest Biotherapeutics Inc have a median target of 7.67, with a high estimate of 10.33 and a low estimate of 5.00. The median estimate represents a +85.14% increase from the last price of 4.14.
The current consensus among 2 polled investment analysts is to Buy stock in Northwest Biotherapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.